| 1 |
Kreso A, Dick JE. Evolution of the cancer stem cell model [J]. Cell Stem Cell, 2014, 14(3): 275-291.
URL
|
| 2 |
Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea—a paradigm shift [J]. Cancer Research, 2006, 66(4): 1883-1890.
|
| 3 |
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J]. Nature medicine, 1997, 3(7): 730-737.
|
| 4 |
Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells [J]. Nature, 2007, 445(7123): 111-115.
|
| 5 |
Chae YC, Kim JH. Cancer stem cell metabolism: target for cancer therapy [J]. BMB Reports, 2018, 51(7): 319-326.
|
| 6 |
Liskova A, Kubatka P, Samec M, et al. Dietary phytochemicals targeting cancer stem cells [J]. Molecules, 2019, 24(5): 899.
|
| 7 |
Wu C, Alman BA. Side population cells in human cancers [J]. Cancer Lett, 2008, 268(1): 1-9.
|
| 8 |
Tang DG, Patrawala L, Calhoun T, et al. Prostate cancer stem/progenitor cells: identification, characterization, and implications [J]. Mol Carcinog, 2007, 46(1): 1-14.
|
| 9 |
Kang MK, Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma [J]. Stem Cells Dev, 2007, 16(5): 837-847.
|
| 10 |
Dalerba P, Clarke MF. Cancer stem cells and tumor metastasis: first steps into uncharted territory [J]. Cell Stem Cell, 2007, 1(3): 241-242.
|
| 11 |
Najafi M, Farhood B, Mortezaee K, et al. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance [J]. J Cancer Res Clin Oncol, 2020, 146(1): 19-31.
|
| 12 |
Pouyafar A, Heydarabad MZ, Abdolalizadeh J, et al. Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage [J]. Cell & Bioscience, 2019, 9(1): 30.
|
| 13 |
Hermann PC, Trabulo SM, Jr BS, et al. multimodal treatment eliminates cancer stem cells and leads to long-term survival in primary human pancreatic cancer tissue xenografts [J]. PloS One, 2013, 8.
|
| 14 |
Jagust P, de Luxán-Delgado B, Parejo-Alonso B, et al. Metabolism-based therapeutic strategies targeting cancer stem cells [J]. Front Pharmacol, 2019, 10: 203.
|
| 15 |
Prost S, Relouzat F, Spentchian M, et al. Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists [J]. Nature, 2015, 525(7569): 380-383.
|
| 16 |
Arceci RJ. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J]. Yearbook of Oncology, 2008, 2008: 286-287.
|
| 17 |
Tsunekuni K, Konno M, Haraguchi N, et al. CD44/CD133-positive colorectal cancer stem cells are sensitive to trifluridine exposure [J]. Sci Rep, 2019, 9(1): 1-8.
|
| 18 |
Barzegar Behrooz A, Syahir A, Ahmad S. CD133: beyond a cancer stem cell biomarker [J]. J Drug Target, 2019, 27(3): 257-269.
|
| 19 |
Li J, Chen JN, Zeng TT, et al. CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy [J]. BMC Cancer, 2016, 16(1): 15.
|
| 20 |
Wu C, Alman BA. Side population cells in human cancers [J]. Cancer Lett, 2008, 268(1): 1-9.
|
| 21 |
Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells [J]. Cancer Research, 2007, 67(10): 4827-4833.
|
| 22 |
Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system [J]. Stem Cells, 2006, 24(3): 506-513.
|
| 23 |
Xiong B, Ma LI, Hu X, et al. Characterization of side population cells isolated from the colon cancer cell line SW480 [J]. Int J Oncol, 2014, 45(3): 1175-1183.
URL
|
| 24 |
Guo Q, Grimmig T, Gonzalez G, et al. ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer [J]. J Biol Chem, 2018, 293(28): 11166-11178.
|
| 25 |
Link W. Cancer Drug Resistance [A]. In: Principles of Cancer Treatment and Anticancer Drug Development: Springer, 2019: 77-85.
|
| 26 |
Liu P, Liao J, Tang Z, et al. Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway [J]. Cell Death & Differentiation, 2014, 21(1): 124-135.
URL
|
| 27 |
Yu M, Ocana A, Tannock IF. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? [J]. Cancer Metastasis Rev, 2013, 32(1-2): 211-227.
URL
|
| 28 |
Akram M. Mini-review on glycolysis and cancer [J]. J Cancer Educ, 2013, 28(3): 454-457.
URL
|
| 29 |
Ishimoto T, Nagano O, Yae T, et al. CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth [J]. Cancer Cell, 2011, 19(3): 387-400.
URL
|
| 30 |
Schieber MS, Chandel NS. ROS links glucose metabolism to breast cancer stem cell and EMT phenotype [J]. Cancer Cell, 2013, 23(3): 265-267.
URL
|
| 31 |
Carr AC, Cook J. Intravenous vitamin C for cancer therapy-identifying the current gaps in our knowledge [J]. Front Physiol, 2018, 9: 1182.
|
| 32 |
Lee WJ. The prospects of vitamin C in cancer therapy [J]. Immune Network, 2009, 9(5): 147.
|
| 33 |
Vincent Z, Urakami K, Maruyama K, et al. CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile [J]. Genes Cancer, 2014, 5(7-8): 250.
|
| 34 |
Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis [J]. J Clin Oncol, 2008, 26(17): 2839.
|
| 35 |
Skvortsova I, Debbage P, Kumar V, et al. Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling [J]. Semi Cancer Biol, 2015, 35: 39-44.
|
| 36 |
Cammareri P, Scopelliti A, Todaro M, et al. Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells [J]. Cancer Res, 2010, 70(11): 4655-4665.
|
| 37 |
Fulda S. Regulation of apoptosis pathways in cancer stem cells [J]. Cancer lett, 2013, 338(1): 168-173.
URL
|
| 38 |
Makino S, Takahashi H, Okuzaki D, et al. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer [J]. Carcinogenesis, 2020 Mar 10. pii: bgaa016.
|
| 39 |
Shafabakhsh R, Reiter RJ, Davoodabadi A, et al. Melatonin as a potential inhibitor of colorectal cancer: molecular mechanisms [J]. J Cell Biochem, 2019, 120(8): 12216-12223.
|
| 40 |
Li G, Liu C, Yuan J, et al. CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential [J]. Clin Exp Metastasis, 2010, 27(7): 517-527.
URL
|
| 41 |
Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer [J]. Cell Stem Cell, 2007, 1(3): 313-323.
URL
|
| 42 |
Khatami F, Tavangar SM, Pour NK. Genomics, proteomics, and metabolomics of cancer stem cells (CSCs) [A]. In: Genomics, Proteomics, and Metabolomics: Springer, 2019: 159-179.
|
| 43 |
Brabletz T, Jung A, Spaderna S, et al. Migrating cancer stem cells—an integrated concept of malignant tumour progression [J]. Nat Rev Cancer, 2005, 5(9): 744-749.
|
| 44 |
Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease [J]. Cell, 2009, 139(5): 871-890.
|
| 45 |
Conacci-Sorrell M, Simcha I, Ben-Yedidia T, et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions [J]. J Cell Biol, 2003, 163(4): 847-857.
|
| 46 |
Pal I, Rajesh Y, Banik P, et al. Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis [J]. Cancer lett, 2019, 452: 254-263.
|
| 47 |
De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression [J]. Nat Rev Cancer, 2013, 13(2): 97-110.
|
| 48 |
Terasaki M, Ikuta M, Kojima H, et al. Dietary fucoxanthin induces anoikis in colorectal adenocarcinoma by suppressing integrin signaling in a murine colorectal cancer model [J]. J Clin Med, 2020, 9(1): 90.
|
| 49 |
An H, Kim JY, Oh E, et al. Salinomycin promotes anoikis and decreases the CD44+/CD24-stem-like population via inhibition of STAT3 activation in MDA-MB-231 cells [J]. PLoS One, 2015, 10(11): e0141919.
|
| 50 |
Kruyt FA, Schuringa JJ. Apoptosis and cancer stem cells: implications for apoptosis targeted therapy [J]. Biochem Pharmacol, 2010, 80(4): 423-430.
URL
|
| 51 |
Kim SY, Hong SH, Basse PH, et al. Cancer stem cells protect non-stem cells from anoikis: bystander effects [J]. J Cell biochem, 2016, 117(10): 2289-2301.
|
| 52 |
Makena MR, Ranjan A, Thirumala V, et al. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance [J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(4): 165339.
|
| 53 |
Kozovska Z, Gabrisova V, Kucerova L. Colon cancer: cancer stem cells markers, drug resistance and treatment [J]. Biomed Pharmacother, 2014, 68(8): 911-916.
URL
|